Eliza Vakana

Eliza Vakana is a scientist, PhD graduate of Northwestern University, Robert H Lurie Comprehensive Cancer Center and division of hematology/oncology, Northwestern University Medical School Chicago, IL 60611.

Contact Info

[email protected]

Recent stories

  • Micrograph of acute myeloid leukaemia (AML)

    Current treatments and future targeted treatments for acute myeloid leukaemiaSubscription

    7 MAR 2016

    While the initial therapy for acute myeloid leukaemia (AML) treatment is relatively standardised, the high incidence of refractory/relapsed disease remains a great challenge. Progress has been made in understanding the pathophysiology of both initial and recurrent disease phases, leading to rigorous pre-clinical studies to identify and selectively target cellular pathways that promote leukaemogenesis. In this article, we discuss the ongoing efforts in overcoming relapsed disease, through a l

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.



виагра в аптеках цена